John Maher

21PUBLICATIONS
29CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jun 16, 2026
Glycosylated extracellular matrix drives immune suppression by modulating macrophage-T cell crosstalk in triple-negative breast cancer.

|May 27, 2026
Optimization of a parallel CAR for B-cell lymphoma via ITAM attenuation and target specificity validation.

|Mar 27, 2026
Re-Tooling of γδ T Cells for Cancer Immunotherapy Using Advanced Manufacturing and Genetic Engineering.

Benjamin J L Lim, John Maher

|Mar 06, 2026
Investigating PAK inhibition in combination with PD-1 blockade to enhance cytotoxic CD8+ T cell-mediated killing and suppress invasion of ovarian cancer cells.

Alexandria R Mitchell, Yiran Chen, Giuseppe Pugliese

|Dec 30, 2025
Prospects for Development and Commercialisation of Allogeneic CAR-Based Therapies for Autoimmune Disease.

Madeleine Osborne, John Maher

|Jul 18, 2024
CAR-T cell technologies that interact with the tumour microenvironment in solid tumours.

Chelsea Alice Taylor, Maya Glover, John Maher

Pageof 4

Frequent Collaborators

2 joint publications

Giuseppe Pugliese

2 joint publications

David M Davies

1 joint publications

John Wahba

1 joint publications

Marina Natoli